Inlexzo (gemcitabine intravesical system): promising data but key questions remain
World Journal of Urology · 2025
DOI: 10.1007/s00345-025-05955-0 ↗At a glance
Leserbrief in World Journal of Urology, 2025. Written by Zarmeen Azhar and 1 co-authors. Institution: Karachi Medical and Dental College, Karachi, Pakistan. zarmeen.azhar123@gmail.com. Major MEDLINE topics: Antimetabolites, Antineoplastic, Carcinoma in Situ, Deoxycytidine, Urinary Bladder Neoplasms. Cited 3 times so far (Crossref); 5 references.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Karachi Medical and Dental College, Karachi, Pakistan. zarmeen.azhar123@gmail.com.
- Karachi Medical and Dental College, Karachi, Pakistan.
Cite
APA
Azhar, Z., & Sadia, Z. (2025). Inlexzo (gemcitabine intravesical system): promising data but key questions remain. World Journal of Urology. https://doi.org/10.1007/s00345-025-05955-0
Vancouver
Azhar Z, Sadia Z. Inlexzo (gemcitabine intravesical system): promising data but key questions remain. World Journal of Urology. 2025. doi:10.1007/s00345-025-05955-0
BibTeX
@article{Azhar2025,
author = {Azhar, Zarmeen and Sadia, Zehra},
title = {Inlexzo (gemcitabine intravesical system): promising data but key questions remain},
journal = {World Journal of Urology},
year = {2025},
doi = {10.1007/s00345-025-05955-0}
}
EUVIMED